November 20, 2023 — InMed.AI (InMed Prognostics Inc.), a pioneer in AI-driven predictive analytics using multi-modal data including text, signal, and image (US Patent No.11263749) and the creator of an end-to-end fully automated organ agnostic imaging platform, announced that it has received the US Food and Drug Administration (FDA) 510(k) clearance for NeuroShield, a fully automated brain geometry-based quantifying analytics tool/cloud platform that uses AI/Dee
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now